Funding
← Back to your selection

Gates Foundation

Activity from announced rounds

Activity in this selectionOct 23, 2026 · Europe · Jan 1, 2026
Rounds participated in
2
Confirmed lead rounds
0
1 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$45.4M
1 disclosed · full round size, not this investor’s share

By stage

Series B1
Undisclosed1

By primary sector

Biotech1
Healthtech1

By country

Netherlands1
Sweden1

Rounds

2 in this selection
Readily Diagnostics

Readily Diagnostics develops molecular tests that help clinicians identify infectious diseases near the patient without relying on a central laboratory.

~$970KGates Foundation grant
Participant
Leyden Laboratories

Develops antibody-based nasal sprays intended to prevent influenza and other respiratory-virus infections.

€40MSeries B
Role not disclosed